Neil Warma
Chief Executive Officer en PROMIS NEUROSCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Cargos activos de Neil Warma
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PROMIS NEUROSCIENCES, INC. | Director/Board Member | 13/05/2021 | - |
Chief Executive Officer | 30/12/2023 | - | |
President | 30/12/2023 | - | |
Independent Dir/Board Member | 13/05/2021 | 30/12/2023 | |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Director/Board Member | 01/09/2009 | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01/01/2014 | - |
Ridgeline Therapeutics | Chairman | 01/01/2019 | - |
TMG Biosciences LLC
TMG Biosciences LLC Miscellaneous Commercial ServicesCommercial Services TMG Biosciences LLC provides biosurveillance and biotechnology consulting services. It assists clients to execute biosurveillance and microbial detection/characterization programs and providing subject matter expertise on biotechnology instrumentation. The company is headquartered in Austin, TX. | Director/Board Member | 01/01/2018 | - |
Historial de carrera de Neil Warma
Antiguos cargos conocidos de Neil Warma.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
I-Mab Biopharma US Ltd. | Corporate Officer/Principal | 01/09/2019 | 01/01/2022 |
BioHealth Care LLC | Chief Executive Officer | 01/01/2018 | 01/01/2019 |
Founder | 01/01/2018 | 01/01/2019 | |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Chief Executive Officer | - | 12/12/2018 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Comptroller/Controller/Auditor | 16/06/2008 | 19/09/2017 |
Director/Board Member | 24/09/2010 | 19/09/2017 | |
Chief Executive Officer | 16/06/2008 | 19/09/2017 | |
Director of Finance/CFO | 02/03/2016 | 19/09/2017 | |
President | 16/06/2008 | 19/09/2017 | |
Corporate Secretary | 16/06/2008 | 24/09/2010 | |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Formación de Neil Warma.
York University | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 10 |
Canadá | 5 |
Alemania | 2 |
Operativa
Director/Board Member | 7 |
Chief Executive Officer | 5 |
President | 5 |
Sectorial
Health Technology | 6 |
Commercial Services | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PROMIS NEUROSCIENCES, INC. | Health Technology |
GENEXINE, INC. | Health Technology |
Empresas privadas | 11 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Commercial Services |
Medexact, Inc. | |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
TMG Biosciences LLC
TMG Biosciences LLC Miscellaneous Commercial ServicesCommercial Services TMG Biosciences LLC provides biosurveillance and biotechnology consulting services. It assists clients to execute biosurveillance and microbial detection/characterization programs and providing subject matter expertise on biotechnology instrumentation. The company is headquartered in Austin, TX. | Commercial Services |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Commercial Services |
Ridgeline Therapeutics | |
I-Mab Biopharma US Ltd. | |
BioHealth Care LLC |
- Bolsa de valores
- Insiders
- Neil Warma
- Experiencia